Logo1
PSHP - 2017 PSHP Annual Assembly
Mr pencil

How would you like your name to appear on your certificate?



What activities did you attend at the event?
Agreement
By completing this form, you attest that you have participated in all selected activities in thier entirety.
PHARMACISTS AND PHARMACY TECHNICIANS ONLY -- Please provide the following:
NABP eProfile ID (ePID):
Date of Birth (MM/DD) - Example September 24 would be 0924:
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Objective 1: Pharmacists and Pharmacy Techs: State updates in disease state and drug therapy management 2
By meeting the above objective my professional competence will increase because I have acquired new strategies to use in my practice.
By meeting the above objective my professional performance will improve because I should be able to implement the new strategies.
By meeting the above objective my patient outcomes should improve due to the implementation of newly-learned strategies.
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
Objective 2: Pharmacists and Pharmacy Techs: Summarize updates to general pharmacy practice
By meeting the above objective my professional competence will increase because I have acquired new strategies to use in my practice.
By meeting the above objective my professional performance will improve because I should be able to implement the new strategies.
By meeting the above objective my patient outcomes should improve due to the implementation of newly-learned strategies.
Objective 3: Pharmacists and Pharmacy Techs: Discuss with updates in the area of patient safety
By meeting the above objective my professional competence will increase because I have acquired new strategies to use in my practice.
By meeting the above objective my professional performance will improve because I should be able to implement the new strategies.
By meeting the above objective my patient outcomes should improve due to the implementation of newly-learned strategies.
Describe the current state and future direction of PSHP
Summarize key points from the ASHP House of Delegates meeting
Discuss key legislative issues relevant to PSHP members
Describe the current state and future direction of PSHP
Summarize key points from the ASHP House of Delegates meeting
Discuss key legislative issues relevant to PSHP members
Differentiate between pharmacy laws and regulations
Discuss the regulatory process in Pennsylvania
Identify some recent regulations and statutes and how pharmacy practice will be changed by the regulation or statute
Differentiate between the government group that amends the Pharmacy Act vs. the group that revises Pharmacy regulations
Identify at least 3 government entities involved in the processing of new regulations
3. List some topics of recent pharmacy regulations and statutes
Define innovation; Define intrapreneurship; Describe opportunities for pharmacists to develop innovation
Intrapreneurship skills and Where are these opportunities found within pharmacy
Share areas where innovation is occurring in pharmacy
Describe what is meant by the term innovation; Describe what is meant by the term intrapreneurship
Discuss how a pharmacy technician can operate innovatively within their organization
Discuss places that are ready for innovative solutions and few that are being proposed
Compare and contrast the notable differences between the 2012 and 2016 severe sepsis and septic shock management guidelines
Describe the evidence based pharmacologic treatment options for severe sepsis and septic shock.
Develop a treatment plan for the management of a patient with septic shock
List the changes to the updated 2016 severe sepsis and septic shock management guidelines
List the definitions for sepsis and septic shock
Describe the Surviving Sepsis Campaign Care Bundles
Discuss the current regulatory framework of pharmacy compounding
Describe the professional responsibilities of hospitals when obtaining outsourced compounded products
Outline practical considerations when considering a 503B Outsource facility
Describe a process for hospital pharmacists when performing a site visit of a current or perspective 503B pharmacy
State safety concerns in outsourcing pharmacy compounding
Identify the sources of regulatory standards for pharmacy compounding
Describe the federal regulatory framework for pharmacy compounding (503A and 503B designations)
Identify the challenges and importance in improving staff engagement
State the various strategies deployed to improve staff engagement scores
Identify the challenges and importance in improving staff engagement
State the various strategies deployed to improve staff engagement scores
Discuss the background and business model behind this initiative
Discuss mentorship and sponsorship and effective strategies to provide each
Discuss the recommendations from the ASHP steering group
Discuss impact of gender shift on the pharmacy profession
Discuss ways to integrate technicians into this initiative
Discuss strategies to implement concepts in your workplace
Describe specific logistical issues that pharmacy students struggle with while on clinical rotations
Name and describe specific free technologies available for preceptors to place useful information for students to access
Reflect upon the utility of using games or polling systems to improve information retention
Explain what information is available in the Pennsylvania Prescription Drug Monitoring Program and how this information can be integrated into routine pharmacy practice
Analyze safety and efficacy of opiate medications and other modalities of pain control; Demonstrate proper use of medication use agreements and urine toxicology screens in family practice setting
Briefly discuss cannabis pharmacology, pharmacokinetics and drug interactions
Present safety and efficacy data for cannabis’ role in pain management
Identify information that may be available in the Pennsylvania Prescription Drug Monitoring Program to aid in patient care
Assess opiate compliance via fill dates and PA PDMP; Review prescriptions for validity
State safety concerns with medical cannabis
Review current regulatory practices of dietary supplements
Demonstrate the evidence of the benefits of dietary supplements in patient care
Assess potential and actual safety issues with dietary supplements
History, Epidemiology, DSHEA and other regulatory actions
Select evidence based clinical trial summaries
Pharmacy and Medical organizations statements, FDA warnings, examples of adulteration
Interactions, case report example
Utilizing the strategies discussed in the presentation, design services for the delivery of medication education at your institution
Utilizing the EMR to identify and delivery medication education
Employing pharmacy learners in the delivery of medication education
State the process for establishing medication education services at your institution
Metrics to track delivery of education
Discuss the nature of a super-utilizer clinic
Discover ways to involve pharmacists in a patient centered medical home model caring for a vulnerable population
Review the importance of a pharmacist on a multi-disciplinary team providing transition of care services
Explain the role of the Ambulatory Collaborative Care Team
Discuss the utility of a pharmacist within an ambulatory collaborative care team
Review common interventions made by pharmacists within the ambulatory collaborative care team
List three root causes of errors with use of subcutaneous insulin in adults.
Describe three best practices that should be in place when allowing use of a patient’s own insulin pump during their hospitalization
Compare the benefits and risks of dispensing insulin in a stock vial, a patient-specific vial, and a pen device
List three errors that can occur with subcutaneously insulin administration in adults
Describe how to label insulin pens to avoid administration to the wrong patient
Explain methods that can be used to differentiate insulin products in storage locations
Describe the attributes of a high reliable organization 
Explain the concept of appreciative inquiry
Identify how appreciative inquiry may assist with achieving high reliability
Apply high reliability into personal practice
Describe why high reliability is important in health care
Identify concepts of high reliability in your current practice
Describe appreciative inquiry
Identify what you do best can help improve medication safety
Construct a comprehensive asthmas treatment plan consistent with current GINA guidelines
Construct a comprehensive COPD treatment plan consistent with current GOLD guidelines
Describe two goals of asthma treatment

Describe two golas of COPD treatment

Compare and contrast drug delivery devices for inhaled asthma and COPD medications
Differentiate between "rescue" and "controller" medications
Please rate the following:
The program was relevant to my work.
Content matched stated objectives.
Usefulness of handouts/AV.
Quality of facilities.
How well did the educational sessions give a balanced view of therapeutic options, including the use of generic names?
If you rated any of the above questions with 'fair,' 'poor,' 'disagree,' or 'strongly disagree' please explain in detail (e.g. session title, speaker name, situtation):
Do you believe this activity was appropriate for the scope of your professional activities?
Was the educational content scientifically sound?
If faculty spoke about off-label or investigational uses of a product, was that information disclosed to you?
Was the mode of education effective to learning?
If you answered "No" to any of the above questions, please explain.
Did you perceive any product/service/company/commercial bias in any educational session you attended or materials you received?
If you answered "Yes" to the above question, please detail the situation below (e.g. session title, speaker name):
Were you solicited by sales personnel in an educational room (other areas do not matter) while you attended this educational activity?
If you answered "Yes" to the above question, please explain in detail (e.g. who, when, where):
How much did you learn as a result of this education program?
What specifically did you learn during this activity that you intend to integrate into your practice?

What questions have arisen in your practice for which you need answers/strategies that you can implement?

What patient/client problems or patient/client challenges do you feel you are not able to address appropriately or to your satisfaction?
What problems are your patients/clients communicating to you that need attention or follow up?

Are you interested in basic, intermediate or advanced level trainings?

What barriers might you have that would interfere with implementation of new information learned from this training?

How can this training (the overall meeting) be improved to better impact competence, performance and/or patient/client outcomes?

Additional comments:

Mr question
Provided by amedco